Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.
Julien BohéHassane AbidiVincent BrunotAmna KlichKada KloucheNicholas SedillotXavier TchenioJean-Pierre QuenotJean-Baptiste RoudautNicolas MottardFabrice ThiollièreJean DellamonicaFlorent WalletBertrand SouweineAlexandre LautretteJean-Charles PreiserJean-François TimsitCharles-Hervé VacheronAli Ait HssainDelphine Maucort-Boulchnull nullPublished in: Intensive care medicine (2021)
Targeting an ICU patient's pre-admission usual glycaemia using a dynamic sliding-scale insulin protocol did not demonstrate a survival benefit compared to maintaining glycaemia below 180 mg/dL.